Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1

Roberts, 2012, Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices task force-2, Value Health, 15, 804, 10.1016/j.jval.2012.06.016 Siebert, 2012, State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force-3, Value Health, 15, 812, 10.1016/j.jval.2012.06.014 Karnon, 2012, Modeling using discrete event simulation: a report of the ISPOR-SMDM modeling good research practices task force-4, Value Health, 15, 821, 10.1016/j.jval.2012.04.013 Pitman, 2012, Dynamic transmission modeling: a report of the ISPOR-SMDM modeling good research practices task force-5, Value Health, 15, 828, 10.1016/j.jval.2012.06.011 Briggs, 2012, Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force-6, Value Health, 15, 835, 10.1016/j.jval.2012.04.014 Eddy, 2012, Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force-7, Value Health, 15, 843, 10.1016/j.jval.2012.04.012 Petrou, 2011, Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting, BMJ, 342, 1766, 10.1136/bmj.d1766 Caro Buxton, 1997, Modelling in economic evaluation: an unavoidable fact of life, Health Econ, 6, 217, 10.1002/(SICI)1099-1050(199705)6:3<217::AID-HEC267>3.0.CO;2-W Steele Lorscheid Kijowski Philips, 2006, Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment, Pharmacoeconomics, 24, 355, 10.2165/00019053-200624040-00006 Weinstein, 2003, Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices—modeling studies, Value Health, 6, 9, 10.1046/j.1524-4733.2003.00234.x Weinstein, 2006, Recent developments in decision-analytic modelling for economic evaluation, Pharmacoeconomics, 24, 1043, 10.2165/00019053-200624110-00002 Brennan, 2006, A taxonomy of model structures for economic evaluation of health technologies, Health Econ, 15, 1295, 10.1002/hec.1148 Siebert, 2003, When should decision-analytic modeling be used in the economic evaluation of health care?, Eur J Health Econ, 4, 143, 10.1007/s10198-003-0205-2 Caro, 2005, Pharmacoeconomic analyses using discrete event simulation, Pharmacoeconomics, 23, 323, 10.2165/00019053-200523040-00003 Stahl, 2008, Modelling methods for pharmacoeconomics and health technology assessment: an overview and guide, Pharmacoeconomics, 26, 131, 10.2165/00019053-200826020-00004 Borshchev Briggs, 2006 Macal, 2010, Tutorial on agent-based modelling and simulation, J Simul, 4, 151, 10.1057/jos.2010.3 Jacobson, 2006, Discrete-event simulation of health care systems Law, 2007 Hunink, 2001 Price, 2011, Model averaging in the presence of structural uncertainty about treatment effects: influence on treatment decision and expected value of information, Value Health, 14, 205, 10.1016/j.jval.2010.08.001 Bilcke, 2011, Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guide, Med Decis Making, 31, 675, 10.1177/0272989X11409240